These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21115979)

  • 1. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
    Rinaldi A; Mian M; Chigrinova E; Arcaini L; Bhagat G; Novak U; Rancoita PM; De Campos CP; Forconi F; Gascoyne RD; Facchetti F; Ponzoni M; Govi S; Ferreri AJ; Mollejo M; Piris MA; Baldini L; Soulier J; Thieblemont C; Canzonieri V; Gattei V; Marasca R; Franceschetti S; Gaidano G; Tucci A; Uccella S; Tibiletti MG; Dirnhofer S; Tripodo C; Doglioni C; Dalla Favera R; Cavalli F; Zucca E; Kwee I; Bertoni F
    Blood; 2011 Feb; 117(5):1595-604. PubMed ID: 21115979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in understanding the biology of marginal zone lymphoma.
    Bertoni F; Rossi D; Zucca E
    F1000Res; 2018; 7():406. PubMed ID: 29657712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?
    Lagoo AS; Haggerty C; Kim Y; Hammons M; Neufeld K; Redher C; Woodward J; Klintworth GK
    Arch Pathol Lab Med; 2008 Sep; 132(9):1405-16. PubMed ID: 18788851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
    Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
    Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.
    Novak U; Basso K; Pasqualucci L; Dalla-Favera R; Bhagat G
    Br J Haematol; 2011 Nov; 155(3):362-5. PubMed ID: 21883140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
    Dallenbach FE; Coupland SE; Stein H
    Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Lee WS; Suh C; Kim HJ
    Int J Hematol; 2010 Oct; 92(3):510-7. PubMed ID: 20838958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many faces of marginal zone lymphoma.
    Zinzani PL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():426-32. PubMed ID: 23233614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.
    Mian M; Kwee I; Rinaldi A; Ponzoni M; Bhagat G; Rossi D; Arcaini L; Gascoyne RD; Mollejo M; Baldini L; Thieblemont C; Gaidano G; Zucca E; Bertoni F
    Br J Haematol; 2014 Mar; 164(6):896-9. PubMed ID: 24329863
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
    de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
    Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal zone lymphomas.
    Zucca E; Rossi D; Bertoni F
    Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type.
    Maes B; Baens M; Marynen P; De Wolf-Peeters C
    Ann Oncol; 2000 May; 11(5):521-6. PubMed ID: 10907943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
    Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
    Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.